| Literature DB >> 17554842 |
Abstract
Individuals and societal groups are questioning the practice of patenting human genetic material in the context of medical research and health care, where diverse ethical, social, and political objections are being raised by critics. A recent case provides a broad legal theory, the common law cause of action, unjust enrichment, and a precedent for challenging the commercialization and patenting of human genetic material.Entities:
Mesh:
Year: 2006 PMID: 17554842
Source DB: PubMed Journal: Ann Health Law